Found: 1
Select item for more details and to access through your institution.
Phase 1b study of pan‐AKT inhibitor vevorisertib alone or with paclitaxel or fulvestrant in PIK3CA/AKT/PTEN‐mutated advanced solid tumors.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1919, doi. 10.1002/cncr.34733
- By:
- Publication type:
- Article